Over last 18 years, there have been three global novel coronavirus outbreaks
Washington (February 4, 2021) – Senator Edward J. Markey (D-Mass.) today reintroduced legislation to support comprehensive research for the creation of a universal coronavirus vaccine or therapeutic. The legislation calls for a total investment of $1 billion – $250 million for each of fiscal years 2021 through 2024 – for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To date, more than two million people worldwide have lost their lives to the coronavirus, 445,000 in the United States, and millions more are fighting this deadly virus every day. Over last 18 years, there have been three global novel coronavirus outbreaks – SARS, MERS, and SARS-CoV-2.
“COVID-19 is the current biothreat we must defeat, but it will not be the last. We must be better prepared in order to avoid the devastating impacts that have been caused by this novel coronavirus,” said Senator Markey. “Investing the resources to find a vaccine that prevents all coronaviruses would be a milestone for global health and safety. The United States can be a global leader in developing a universal coronavirus vaccine or therapeutic that prevents or contains the next biothreat. We have a responsibility to provide dedicated and robust resources to our greatest minds in order to prevent this unimaginable loss from ever occurring again.”
A copy of the legislation can be found HERE
On February 3, 2020 Senator Markey queried NIAID about its efforts to design and produce a universal coronavirus vaccine. Then NIAID administrator Dr. Anthony Fauci previously said of the current outbreak that a universal coronavirus vaccine is possible and worth considering.